Clinical impact of PSMA-based (18)F—DCFBC PET/CT imaging in patients with biochemically recurrent prostate cancer after primary local therapy

PURPOSE: The purpose of our study was to assess (18)F–DCFBC PET/CT, a PSMA targeted PETagent, for lesion detection and clinical management of biochemical relapse in prostate cancer patients after primary treatment. METHODS: This is a prospective IRB-approved study of 68 patients with documented bioc...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Eur J Nucl Med Mol Imaging
Egile Nagusiak: Mena, Esther, Lindenberg, Maria L., Shih, Joanna H., Adler, Stephen, Harmon, Stephanie, Bergvall, Ethan, Citrin, Deborah, Dahut, William, Ton, Anita T., McKinney, Yolanda, Weaver, Junaita, Eclarinal, Philip, Forest, Alicia, Afari, George, Bhattacharyya, Sibaprasad, Mease, Ronnie C., Merino, Maria J., Pinto, Peter, Wood, Bradford J., Jacobs, Paula, Pomper, Martin G., Choyke, Peter L., Turkbey, Baris
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2017
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7983162/
https://ncbi.nlm.nih.gov/pubmed/28894899
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00259-017-3818-x
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak